Aller au contenu principal
Profil bibliographique

Jacques Corcos

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

363Publications signalées
7333Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Urinary Bladder and Prostate ResearchPelvic floor disorders treatmentsUrinary Tract Infections ManagementUrological Disorders and TreatmentsBladder and Urothelial Cancer Treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Clinical and urodynamic indicators of non-response to OnabotulinumtoxinA in idiopathic overactive bladder

Samer Shamout, Hani Kabbara, Claudia Covarrubias, Jacques Corcos et autres

BACKGROUND: Onabotulinum toxin-A (BoNT/A) intradetrusor injection is an established, effective, and safe treatment for overactive bladder (OAB) refractory to anticholinergics. Although primary non-response to BoNT/A is infrequent, it remains clinically relevant. We investigated whether baseline clinical, demographic, or urodynamic characteristics could predict …

ca, us (code pays fourni par la source)

0 citations Canadian Journal of Urology
Accès ouvert 2025 article OpenAlex

Management of bladder outlet obstruction after stress urinary incontinence surgery in women: Results of a North American Survey among surgeons

Andry Perrin, Lysanne Campeau, Jas Singh, Jacques Corcos

ABSTRACT Introduction To gather expert opinion and describe trends in the management of early and prolonged bladder outlet obstruction following stress urinary incontinence surgery. Methods Expert physicians and members of the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), were …

ca (code pays fourni par la source)

0 citations Continence
2025 article OpenAlex

From immunotherapy to autoimmunity: reactive arthritis following intravesical BCG

Saad Alqasem, Sophie Wojcik, Jacques Corcos

Reactive arthritis (ReA) is recognised as a sterile inflammatory arthritis triggered by infections or other antigens, including intravesical BCG used to treat non-muscle-invasive bladder cancer. Although BCG immunotherapy is highly effective, its side effects can extend beyond the genitourinary tract. We present …

sa, ca (code pays fourni par la source)

1 citation BMJ Case Reports
Accès ouvert 2023 article OpenAlex

Nonneurogenic female bladder outlet obstruction: Conservative and medical management

Andry Perrin, Jacques Corcos

INTRODUCTION: In nonneurogenic female bladder outlet obstruction (BOO), management goals include reduction of outlet resistance to increase urinary outflow and improve bladder voiding to prevent or reduce lower and upper urinary tract (LUT and UUT) function deterioration, by correcting the underlying etiology. …

ca (code pays fourni par la source)

5 citations Neurourology and Urodynamics
2023 editorial OpenAlex

Editorial: Editors' introduction: Bladder outflow obstruction in women

Lysanne Campeau, Jacques Corcos

Dear Readers, We are delighted to present to you this special section of NUU journal dedicated to the comprehensive exploration and treatment of bladder outlet obstruction (BOO) in women. BOO, a condition often underrepresented in medical literature, has significant implications for female …

ca (code pays fourni par la source)

0 citations Neurourology and Urodynamics
Accès ouvert 2023 article OpenAlex

The Utility of Urodynamic Studies in Neuro-Urological Patients

Andry Perrin, Jacques Corcos

INTRODUCTION: The utility of a clinical tool lies in its clinical performance evaluation and describes the relevance and usefulness of that tool in a medical setting. The utility of urodynamic and video-urodynamic studies in the management of specific urodynamic profiles in the …

ca (code pays fourni par la source)

15 citations Biomedicines

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.